Results 161 to 170 of about 36,733,388 (297)

Argonne National Laboratory Report ANL-77-62

, 1977
Quarterly report on the activities of the Argonne National Laboratory Materials Science Division regarding studies of erosive wear, nondestructive testing, corrosion, chemical degradation, and failure ...
Argonne National Laboratory. Materials Science Division., Ellingson, W. A.   +1 more
core  

Problem-Based Learning (PBL) Model in Teaching Medical Laboratory Science at University of Hawai'i. [PDF]

Hawaii J Health Soc Welf
Nxedhlana V.
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Argonne National Laboratory Report ANL-78-54

, 1978
Quarterly report on the activities of the Argonne National Laboratory Materials Science Division regarding studies on ceramic (refractory) and metallic materials being used or intended for use in coal-conversion ...
Argonne National Laboratory. Materials Science Division., Ellingson, W. A.   +1 more
core  

Examining the benefits of industry clinical placements for medical laboratory science academics. [PDF]

Lab Med
Pouniotis D, Sharp L, Vlahos R, Shibeeb S.   +3 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Review questions for medical laboratory technicians.

, 1951
Pub. by the association under its earlier name: California Association of Medical Laboratory Technicians.Mode of access ...
California Association of Medical Laboratory Technicians. Santa Barbara Chapter.
core  

Alteration in Oxidative Stress Enzymes and Proteins by Datura metel Stramonium Hydroethanolic Root Extract Promotes Hippocampus and Cerebral Cortex Neurons Damage in Adult Sprague Dawley Rats

Substance Abuse and Rehabilitation
Yibala Ibor oboma,1,2 God’sman C Eberechukwu1,3 1Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University Wilberforce Island Bayelsa State, Amassoma, Nigeria; 2Department of Medical ...
oboma YI, Eberechukwu GC
doaj  

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Digital case-library and dual-mentor teaching for medical laboratory science internships in China: a historical comparison educational evaluation. [PDF]

Front Med (Lausanne)
Ding Y, Zhang H, Zhang W, Wang Y, Zhang H, Wu Y, Ma M.   +6 more
europepmc   +1 more source